I. Angel

815 total citations
35 papers, 670 citations indexed

About

I. Angel is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, I. Angel has authored 35 papers receiving a total of 670 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Cellular and Molecular Neuroscience and 11 papers in Physiology. Recurrent topics in I. Angel's work include Receptor Mechanisms and Signaling (14 papers), Neuroscience and Neuropharmacology Research (7 papers) and Neuropeptides and Animal Physiology (7 papers). I. Angel is often cited by papers focused on Receptor Mechanisms and Signaling (14 papers), Neuroscience and Neuropharmacology Research (7 papers) and Neuropeptides and Animal Physiology (7 papers). I. Angel collaborates with scholars based in France, Colombia and United States. I. Angel's co-authors include S Z Langer, A. Coste, Etienne Guillot, I. Ophir, Salomón Z. Langer, Daniel M. Michaelson, S. Arbilla, Philippe Lluel, Denis Martin and Philippe Pichat and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Endocrinology.

In The Last Decade

I. Angel

34 papers receiving 627 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I. Angel France 16 267 232 171 119 94 35 670
Alberto Meli Italy 12 186 0.7× 297 1.3× 198 1.2× 60 0.5× 66 0.7× 16 601
Douglas C. Eikenburg United States 13 628 2.4× 417 1.8× 268 1.6× 48 0.4× 199 2.1× 42 1.1k
K P Minneman United States 12 696 2.6× 427 1.8× 263 1.5× 51 0.4× 174 1.9× 14 1.0k
Agnès Choppin United States 14 434 1.6× 294 1.3× 126 0.7× 46 0.4× 62 0.7× 26 830
Chide Han China 18 767 2.9× 521 2.2× 308 1.8× 112 0.9× 105 1.1× 32 1.1k
T A Branchek United States 7 514 1.9× 464 2.0× 127 0.7× 45 0.4× 140 1.5× 7 833
Richard Roberts United Kingdom 19 240 0.9× 126 0.5× 276 1.6× 131 1.1× 82 0.9× 61 846
Mark A. Osinski United States 16 273 1.0× 288 1.2× 135 0.8× 152 1.3× 43 0.5× 31 656
Kalina Venkova United States 17 226 0.8× 265 1.1× 251 1.5× 115 1.0× 31 0.3× 56 887
Carlo Alberto Maggi Italy 23 616 2.3× 714 3.1× 447 2.6× 95 0.8× 32 0.3× 35 1.2k

Countries citing papers authored by I. Angel

Since Specialization
Citations

This map shows the geographic impact of I. Angel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Angel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Angel more than expected).

Fields of papers citing papers by I. Angel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Angel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Angel. The network helps show where I. Angel may publish in the future.

Co-authorship network of co-authors of I. Angel

This figure shows the co-authorship network connecting the top 25 collaborators of I. Angel. A scholar is included among the top collaborators of I. Angel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Angel. I. Angel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Angel, I., et al.. (2024). Fuerza prensil y biomarcadores en pacientes con enfermedad renal crónica en hemodiálisis. Revista Colombiana de Nefrología. 11(1). 1 indexed citations
2.
Angel, I., et al.. (2024). Quality of life and grip strength in patients with CKD. Revista Colombiana de Nefrología. 11(3). 1 indexed citations
3.
4.
5.
Martin, Denis, et al.. (1998). Relationship between the effects of alfuzosin on rat urethral and blood pressures and its tissue concentrations. Life Sciences. 63(3). 169–176. 23 indexed citations
6.
Goldhill, J, Philippe Pichat, Nigel Roome, I. Angel, & S. Arbilla. (1998). Effect of mizolastine on visceral sensory afferent sensitivity and inflammation during experimental colitis.. PubMed. 48(2). 179–84. 20 indexed citations
7.
Martin, Denis, et al.. (1997). Comparative Alpha-1 Adrenoceptor Subtype Selectivity and Functional Uroselectivity of Alpha-1 Adrenoceptor Antagonists. Journal of Pharmacology and Experimental Therapeutics. 282(1). 228–235. 72 indexed citations
8.
Bovy, Philippe R., et al.. (1997). Asymmetric synthesis of both enantiomers of 2-(dimethylamino)-1-[3-methoxy-2-(1-methylethoxy)phenyl]ethanol. European Journal of Medicinal Chemistry. 32(11). 881–888. 1 indexed citations
9.
10.
Guillot, Etienne, A. Coste, & I. Angel. (1996). Involvement of capsaicin-sensitive nerves in the regulation of glucose tolerance in diabetic rats. Life Sciences. 59(12). 969–977. 33 indexed citations
11.
Guillot, Etienne, A. Coste, & I. Angel. (1995). Alpha2-adrenoceptors and the regulation of glucose, insulin and amylin levels in diabetic rats. Life Sciences. 57(23). 2081–2090. 5 indexed citations
12.
Angel, I., et al.. (1995). [3H]Cirazoline as a Tool for the Characterization of Imidazoline Sites. Annals of the New York Academy of Sciences. 763(1). 112–124. 17 indexed citations
13.
Angel, I., et al.. (1993). Litoxetine: a selective 5-HT uptake inhibitor with concomitant 5-HT3 receptor antagonist and antiemetic properties. European Journal of Pharmacology. 232(2-3). 139–145. 29 indexed citations
14.
15.
Angel, I., et al.. (1991). The binding site for [3H]glibenclamide in the rat cerebral cortex does not recognize K‐channel agonists or antagonists other than sulphonylureas. Fundamental and Clinical Pharmacology. 5(2). 107–115. 23 indexed citations
16.
Langer, S Z & I. Angel. (1991). Pre- and postsynaptic alpha-2 adrenoceptors as target for drug discovery. PubMed. 34. 171–177. 8 indexed citations
17.
Angel, I., et al.. (1990). Pharmacological characterization of alpha-2 adrenergic receptor subtype involved in the release of insulin from isolated rat pancreatic islets.. Journal of Pharmacology and Experimental Therapeutics. 254(3). 883–887. 54 indexed citations
18.
Angel, I., et al.. (1990). SL 84.0418: a new alpha-2 antagonist with anti-hyperglycaemic properties. European Journal of Pharmacology. 183(3). 990–991. 2 indexed citations
19.
Angel, I.. (1988). The use of microtiter plates for the simple and sensitive determination of insulin by an ELISA method. Cellular and Molecular Life Sciences. 44(10). 877–879. 10 indexed citations
20.
Angel, I., et al.. (1988). Pharmacological characterization of the hyperglycemia induced by alpha-2 adrenoceptor agonists.. Journal of Pharmacology and Experimental Therapeutics. 246(3). 1098–1103. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alberto Meli Breakdown of academic impact, for papers by Douglas C. Eikenburg Breakdown of academic impact, for papers by K P Minneman Breakdown of academic impact, for papers by Agnès Choppin Breakdown of academic impact, for papers by Chide Han Breakdown of academic impact, for papers by T A Branchek Breakdown of academic impact, for papers by Richard Roberts Breakdown of academic impact, for papers by Mark A. Osinski Breakdown of academic impact, for papers by Kalina Venkova Breakdown of academic impact, for papers by Carlo Alberto Maggi
Rankless by CCL
2026